相关实验视频

Updated: Jan 13, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

通过便微生物群转移改善性结肠炎的前景:非典型的供体微生物群可以提高成功率

Maarten van de Guchte¹, Stanislas Mondot¹, Julie Cadiou¹

¹University Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.

|January 11, 2026

概括

非典型的便微生物群转移 (FMT) 对性结肠炎 (UC) 治疗有希望. 这项研究发现,在老鼠模型中,特定的供体微生物群,而不是自身的FMT,有效地恢复了肠道健康,这表明了新的治疗方向.

科学领域:

微生物学微生物学
胃肠病学胃肠病学
免疫学免疫学免疫学

背景情况:

便微生物群转移 (FMT) 是一种针对性结肠炎 (UC) 的试验性治疗方法,成功率各不相同.
当前的FMT策略往往涉及试验和错误,以提高有效性.
一个概念模型预测非典型的供体微生物群可能会增强FMT结果.

研究的目的:

实验验证预测,非典型的供体微生物群可以提高FMT的疗效.
在大鼠模型中,研究自身性和异源性FMT对异菌性肠道生态系统的影响.
为改善UC治疗中的FMT策略提供合理的基础.

主要方法:

在老鼠中诱导慢性低度炎症和失生症模型.
自主性FMT,来自两个供体菌株的非典型异性FMT或没有FMT (对照) 的使用.
在FMT后评估微生物群恢复和远端结肠组织学.

主要成果:

与对照组相比,自主性FMT显示微生物群恢复的改善极小.
来自特定供体菌株的非典型异构性FMT显著恢复了健康的微生物群.
一些成功的异构性FMT病例与健康的远端结肠组织学有关.

结论:

非典型的异质微生物群具有显著的潜力,可以提高UC的FMT疗效.
监测FMT的成功需要评估临床症状和微生物群组成.
这些发现支持了一个概念模型,有利于UC的共生疗法,针对微生物群和炎症.

关键词:

性结肠炎是一种先进的诊断先进的诊断是指先进的诊断.替代性的稳定状态替代性的稳定状态供体选择供体选择便微生物群的转移 (FMT)概念证明的概念证明治疗创新是一种治疗创新.

更多相关视频

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Murine Fecal Isolation and Microbiota Transplantation

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

相关概念视频

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...